Be a part of Open Innovation
Apply for one of our many programmes and collaborate with us
We invite you to explore our preclinical, clinical or other offerings to identify either a programme or a compound of interest and submit a brief, non-confidential concept proposal to us for review.
We accept submissions all year around for our preclinical and clinical research programmes. Additionally, we open more targeted challenges every six months to find new collaborators who can rapidly bring in real innovations and solutions to real challenges faced by our teams.
Configure Image Component
Application Process
Carousel Slide-1 Content Section Begins
Configure Image Component
Submitting a proposal
- Identify a programme or compound of interest to collaborate with us on
- Read the Instructions for Authors
- Develop a short Concept Proposal for initial review – please include only non-confidential information at this stage
- If you want to share confidential data to support your proposal, let us know in your application and we can arrange after the initial review phase
- Submit your proposal here
Carousel Slide-1 Content Section Ends
Carousel Slide-2 Content Section Begins
Configure Image Component
AstraZeneca review and feedback
- Proposals are reviewed based on:
- Scientific merit, strength and uniqueness of hypothesis
- Compelling unmet patient or medical needs
- Technical feasibility
- Potential impact on patient outcomes
- Advantages over current standard of care
- Feedback and decisions will be shared within 8-10 weeks
- If accepted, we will ask you to develop a full project proposal with defined milestones, timelines, responsibilities and funding needs
Carousel Slide-2 Content Section Ends
Carousel Slide-3 Content Section Begins
Configure Image Component
Decisions and agreements
- Once your proposal is accepted, we work closely to mutually agree the terms and conditions of the collaboration with your organisation
- This includes bidirectional Confidential Disclosure Agreements and/or Material Transfer Agreements
- For clinical compounds, this could also include bridging CMC regulatory documentation for IND filings
Carousel Slide-3 Content Section Ends
Carousel Slide-4 Content Section Begins
Configure Image Component
Collaboration
- Upon project launch, principal investigators retain full control over execution of the study
- In addition to agreed resources, we offer support through regular meetings and reports to discuss progress and enable course correction as needed
- We also provide support by identifying opportunities for follow-on studies, grant applications and publications
Carousel Slide-4 Content Section Ends
Submitting a proposal
AstraZeneca review and feedback
Decisions and agreements
Collaboration
Configure Accordion Item: - Submitting a proposal
accordionUniqueIDDescription -
Configure Accordion Item: - Submitting a proposal
Configure Image Component
Submitting a proposal
- Identify a programme or compound of interest to collaborate with us on
- Read the Instructions for Authors
- Develop a short Concept Proposal for initial review – please include only non-confidential information at this stage
- If you want to share confidential data to support your proposal, let us know in your application and we can arrange after the initial review phase
- Submit your proposal here
Configure Accordion Item: - AstraZeneca review and feedback
accordionUniqueIDDescription -
Configure Accordion Item: - AstraZeneca review and feedback
Configure Image Component
AstraZeneca review and feedback
- Proposals are reviewed based on:
- Scientific merit, strength and uniqueness of hypothesis
- Compelling unmet patient or medical needs
- Technical feasibility
- Potential impact on patient outcomes
- Advantages over current standard of care
- Feedback and decisions will be shared within 8-10 weeks
- If accepted, we will ask you to develop a full project proposal with defined milestones, timelines, responsibilities and funding needs
Configure Accordion Item: - Decisions and agreements
accordionUniqueIDDescription -
Configure Accordion Item: - Decisions and agreements
Configure Image Component
Decisions and agreements
- Once your proposal is accepted, we work closely to mutually agree the terms and conditions of the collaboration with your organisation
- This includes bidirectional Confidential Disclosure Agreements and/or Material Transfer Agreements
- For clinical compounds, this could also include bridging CMC regulatory documentation for IND filings
Configure Accordion Item: - Collaboration
accordionUniqueIDDescription -
Configure Accordion Item: - Collaboration
Configure Image Component
Collaboration
- Upon project launch, principal investigators retain full control over execution of the study
- In addition to agreed resources, we offer support through regular meetings and reports to discuss progress and enable course correction as needed
- We also provide support by identifying opportunities for follow-on studies, grant applications and publications
Configure Image Component
A word on Intellectual Property
"Addressing Intellectual Property (IP) is key to promoting open innovation. It’s essential that we build mutual trust and reward innovation – this means if one party generates IP, they get rewarded and recognised for it. If we create new IP as a result of our collaboration, then we work out how to share it on a case-by-case basis in a way that works for both parties."
Kelly Gray, Open Innovation Programme Manager
You may also be interested in
Configure Image Component
Configure Image Component
Configure Image Component
Modal Window Component Section Begins
Configure Modal Window Component -
#popup-1626252392387
Modal Window Component Section Ends